Paper20072833
Dasatinib.
Lindauer M and 1 other. Recent Results Cancer Res, 2010. Cited by 59 papers, by iCite.
Cite this record
ConductScience Library. Dasatinib. Papers, record 20072833. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20072833
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Major topic |
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | Major topic |
| Protein Kinase Inhibitors | Major topic |
| Pyrimidines | Major topic |
| Thiazoles | Major topic |
| Clinical Trials as Topic | |
| Dasatinib | |
| Humans | |
| Oncogene Proteins v-abl | |
| Proto-Oncogene Proteins c-kit | |
| Receptor, Platelet-Derived Growth Factor alpha | |
| src-Family Kinases |
Source PubMed
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 59 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42909951 | Cellular senescence in multiple sclerosis: hallmarks, immunosenescence, and therapeutic implications. | Front Immunol | 2026 | https://conductscience.org/library/papers/42909951 | PubMed |
| 41150770 | Molecular Mechanisms and Clinical Implications of Fibroblast Growth Factor Receptor 2 Signaling in Gastrointestinal Stromal Tumors. | Curr Issues Mol Biol | 2025 | https://conductscience.org/library/papers/41150770 | PubMed |
| 40733131 | Tyrosine Kinase Inhibitors for Gastrointestinal Stromal Tumor After Imatinib Resistance. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40733131 | PubMed |
| 40144337 | Periorbital edema and phototoxic rash associated with dasatinib: A case report. | SAGE Open Med Case Rep | 2025 | https://conductscience.org/library/papers/40144337 | PubMed |
| 40031988 | Harnessing p53 for targeted cancer therapy: new advances and future directions. | Transcription | 2025 | https://conductscience.org/library/papers/40031988 | PubMed |
| 39765417 | Senescent brain cell types in Alzheimer's disease: Pathological mechanisms and therapeutic opportunities. | Neurotherapeutics | 2025 | https://conductscience.org/library/papers/39765417 | PubMed |
| 39005125 | Impact of Tyrosine Kinase Inhibitors (TKIs) on Growth in Children and Adolescents with Chronic Myeloid Leukemia: A Systematic Review. | Curr Pharm Des | 2024 | https://conductscience.org/library/papers/39005125 | PubMed |
| 37679434 | Senolytic therapy in mild Alzheimer's disease: a phase 1 feasibility trial. | Nat Med | 2023 | https://conductscience.org/library/papers/37679434 | PubMed |
| 37089957 | Analysis of intracellular tyrosine phosphorylation in circulating neutrophils as a rapid assay for the in vivo effect of oral tyrosine kinase inhibitors. | Front Pharmacol | 2023 | https://conductscience.org/library/papers/37089957 | PubMed |
| 36915875 | Biomarker identification of immune-related genes in pheochromocytoma and paraganglioma. | Transl Androl Urol | 2023 | https://conductscience.org/library/papers/36915875 | PubMed |
| 36446524 | Loss of cell-cell adhesion triggers cell migration through Rac1-dependent ROS generation. | Life Sci Alliance | 2023 | https://conductscience.org/library/papers/36446524 | PubMed |
| 35129779 | Transport and metabolism of tyrosine kinase inhibitors associated with chronic myeloid leukemia therapy: a review. | Mol Cell Biochem | 2022 | https://conductscience.org/library/papers/35129779 | PubMed |
| 33792436 | Dasatinib self-assembled nanoparticles decorated with hyaluronic acid for targeted treatment of tumors to overcome multidrug resistance. | Drug Deliv | 2021 | https://conductscience.org/library/papers/33792436 | PubMed |
| 30112222 | Dasatinib-Induced Hypopigmentation in Pediatric Patient with Chronic Myeloid Leukemia: A Case Report and Review of the Literature. | Case Rep Dermatol Med | 2018 | https://conductscience.org/library/papers/30112222 | PubMed |
| 29330550 | A Metabolomics Pilot Study on Desmoid Tumors and Novel Drug Candidates. | Sci Rep | 2018 | https://conductscience.org/library/papers/29330550 | PubMed |
| 28684771 | The Src family kinase inhibitor dasatinib delays pain-related behaviour and conserves bone in a rat model of cancer-induced bone pain. | Sci Rep | 2017 | https://conductscience.org/library/papers/28684771 | PubMed |
| 26261215 | Integrated analysis of numerous heterogeneous gene expression profiles for detecting robust disease-specific biomarkers and proposing drug targets. | Nucleic Acids Res | 2015 | https://conductscience.org/library/papers/26261215 | PubMed |
| 26187774 | Emerging Agents for the Treatment of Advanced, Imatinib-Resistant Gastrointestinal Stromal Tumors: Current Status and Future Directions. | Drugs | 2015 | https://conductscience.org/library/papers/26187774 | PubMed |
| 26155085 | Optic neuropathy secondary to dasatinib in the treatment of a chronic myeloid leukemia case. | Saudi J Ophthalmol | 2015 | https://conductscience.org/library/papers/26155085 | PubMed |
| 25779657 | Elevated Src family kinase activity stabilizes E-cadherin-based junctions and collective movement of head and neck squamous cell carcinomas. | Oncotarget | 2015 | https://conductscience.org/library/papers/25779657 | PubMed |
Genes7
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| ABL1 | 25 | PubTator's text mining | https://conductscience.org/library/genes/25 | NCBI Gene |
| FYN | 2534 | PubTator's text mining | https://conductscience.org/library/genes/2534 | NCBI Gene |
| KIT | 3815 | PubTator's text mining | https://conductscience.org/library/genes/3815 | NCBI Gene |
| LCK | 3932 | PubTator's text mining | https://conductscience.org/library/genes/3932 | NCBI Gene |
| PDGFRA | 5156 | PubTator's text mining | https://conductscience.org/library/genes/5156 | NCBI Gene |
| PDGFRB | 5159 | PubTator's text mining | https://conductscience.org/library/genes/5159 | NCBI Gene |
| SRC | 6714 | PubTator's text mining | https://conductscience.org/library/genes/6714 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/20072833
GET https://conductscience.org/api/papers/v1/20072833/cited_by?page=2